ARTL
Artelo Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$5.40M
P/E Ratio
—
EPS
$-37.56
Beta
0.41
52W High
$85.80
52W Low
$2.96
50-Day MA
$4.91
200-Day MA
$14.68
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Artelo Biosciences Inc
Artelo Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. The company is headquartered in La Jolla, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-7.44M |
| Operating Margin | 0.00% |
| Return on Equity | -1625.00% |
| Return on Assets | -190.10% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-1.89 |
| Price-to-Book | 0.50 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 1.22 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 817,130 |
| Float | 705,070 |
| % Insiders | 0.40% |
| % Institutions | 4.16% |
Data last updated: 4/7/2026